Autism spectrum disorder (ASD) is diagnosed when individuals exhibit characteristic behaviors that include repetitive actions, decreased social interactions and impaired communication. Curiously, many individuals with ASD also suffer from gastrointestinal (GI) issues, such as abdominal cramps and constipation. Using the co-occurrence of brain and gut problems in ASD as their guide, researchers are investigating a new therapy.
Researchers in China, working on the optimization...
New findings by Univ. of California, Irvine (UC Irvine) and German chemists about how cataracts...
A group of Illinois researchers, led by Centennial Chair Prof. of the Dept. of Chemical and Biomolecular Engineering Huimin Zhao, has demonstrated the use of an innovative DNA engineering technique to discover potentially valuable functions hidden within bacterial genomes. Their work was reported in a Nature Communications article.
DNAnexus has announced a collaboration with Stanford Univ. that has resulted in a new 1000 Genomes Project data set of genetic variation. Launched in January 2008, the 1000 Genomes Project was the first international effort to sequence a large number of individual genomes with the goal of developing a comprehensive and freely accessible resource on human genetic variation.
Scientists are reporting development of a squishy gel that, when compressed at a key location such as a painful knee joint, releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most.
Sometimes the cure can be worse than the disease. Pharmaceutical drugs are known for their potential side effects, and an important aspect of personalized medicine is to tailor therapies to individuals to reduce the chances of adverse events. Now researchers from North Carolina State Univ. have updated an extensive toxicology database so that it can be used to track information about therapeutic drugs and their unintentional toxic effects.
An international multidisciplinary team including researchers at the Univ. of Illinois at Urbana/Champaign and the National Institute of Biomedical Imaging and Bioengineering has developed a sophisticated ”electronic skin” that adheres non-invasively to human skin, conforms well to contours, and provides a detailed temperature map of any surface of the body.
Scientists at Penn State Univ. have developed a method that enables a more accurate prediction of how ribonucleic acid molecules (RNAs) fold within living cells, shedding new light on how plants, as well as other living organisms, respond to environmental conditions. The advance was made possible by the ability to analyze more than 10,000 RNA molecules in a single cell.
Much of what is known about sensory touch and hearing cells is based on indirect observation. Scientists know that these tiny cells are sensitive to changes in force and pressure. But to truly understand how they function, scientists must be able to manipulate them directly. Now, Stanford Univ. scientists are developing a set of tools that are small enough to stimulate an individual nerve or group of nerves.
X-rays transformed medicine a century ago by providing a noninvasive way to detect internal structures in the body. Still, they have limitations: X-rays cannot image the body’s soft tissues, except with the use of contrast-enhancing agents that must be swallowed or injected, and their resolution is limited. But a newly developed approach could dramatically change that.
Counselors helping people use the federal government's online health exchange are giving mixed reviews to the updated site, with some zipping through the application process while others are facing the same old sputters and even crashes. The Obama administration had promised a vastly improved shopping experience on healthcare.gov by the end of November, and this is the first week for users to test the updated site.
Researchers have identified a protein that causes loss of function in immune cells combating HIV. The scientists report in a paper appearing online in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells’ ability to combat the virus that causes AIDS.
Researchers have tried for decades to understand the undulations and gyrations that allow transport proteins to shuttle molecules from one side of a cell membrane to the other. Now scientists report that they have found a way to penetrate the mystery. They have worked out every step in the molecular dance that enables one such transporter to do its job.
Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far. Now, researchers have developed a new type of nanoparticle that can be delivered orally and absorbed through the digestive tract, allowing patients to simply take a pill instead of receiving injections.
When sunlight strikes a photosynthesizing organism, energy flashes between proteins just beneath its surface until it is trapped as separated electric charges. Improbable as it may seem, these tiny hits of energy eventually power the growth and movement of all plants and animals. They are literally the sparks of life.
Biogen Idec said Monday the U.S. Food and Drug Administration (FDA) extended its review of Alprolix, a drug designed to treat hemophilia B. Biogen Idec said the FDA extended its review by three months. The move came after the agency asked Biogen for more information about validation of part of the Alprolix manufacturing process.
Nature builds flawless diamonds, sapphires and other gems. Now a Northwestern Univ. research team is the first to build near-perfect single crystals out of nanoparticles and DNA, using the same structure favored by nature. The research group developed the “recipe” for using nanomaterials as atoms, DNA as bonds and a little heat to form tiny crystals. This single-crystal recipe builds on superlattice techniques.
Bruker Corp. has announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The clearance marks progress in Bruker’s efforts to develop MALDI-TOF mass spectrometry into the most advanced platform for clinical microbiology identification.
Univ. of Arizona agricultural and biosystems engineering associate professor Jeong-Yeol Yoon and cardiology professor Dr. Marvin Slepian are testing nanotextured surfaces to improve how cardiovascular implant devices are attached in the body. The goal is to create a selectively sticky surface, favoring endothelial cell attachment, without favoring platelet attachment.
New research from North Carolina State Univ. shows that iron may play a role in preserving ancient tissues within dinosaur fossils, but also may hide them from detection. The finding could open the door to the recovery of more ancient tissues from within fossils.
Researchers have made inroads into tackling a bacterium that plagues hospitals and is highly resistant to most antibiotics. They determined the 3-D structure and likely function of a new protein in this common bacterium that attacks those with compromised immune systems.
A new innovation may help us deal with post-Thanksgiving guilt: Biotechnologists have constructed a genetic regulatory circuit from human components that monitors blood-fat levels. In response to excessive levels, it produces a messenger substance that signals satiety to the body. Tests on obese mice reveal that this helps them to lose weight.
Damage to or theft of technical equipment represents a dramatic financial and scientific loss to researchers. Scientists in Germany decided to find out whether the information content and tone of labels attached to the equipment could reduce the incidence of vandalism. They found that a friendly, personal label reduced the interaction of people with the equipment in comparison with neutral or threatening labels.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits. In a warning letter posted online Monday, FDA regulators say that the Silicon Valley company has not shown that its tests are safe or effective despite "more than 14 face-to-face and teleconference meetings" and "hundreds of email exchanges."
The blood stem cells that live in bone marrow are at the top of a complex family tree. Such stem cells split and divide down various pathways that ultimately produce red cells, white cells and platelets. These “daughter” cells must be produced at a rate of about one million per second to constantly replenish the body’s blood supply. Researchers have long wondered what allows these stem cells to persist for decades, until now.
A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins. The other drugs can contribute to a common side effect of taking statins—muscle pain—and often led people to discontinue use of a medication that could otherwise help save their life, researchers learned.
A method by Rice Univ. researchers to model the way proteins fold, and sometimes misfold, has revealed branching behavior that may have implications for Alzheimer’s and other aggregation diseases. In an earlier study of the muscle protein titin, Rice chemist Peter Wolynes and his colleagues analyzed the likelihood of misfolding in proteins, in which domains become entangled with like sequences on nearby chains.
- Page 1